期刊
PEDIATRIC BLOOD & CANCER
卷 52, 期 5, 页码 559-565出版社
WILEY-LISS
DOI: 10.1002/pbc.21889
关键词
ALL; developing countries; leukemia
Cure rates for children with acute lymphoblastic leukemia (ALL) are 80-85% in high-income countries (HICs) in North America and Western Europe. However, (Lire rates are much h lower it) many low-income countries (LICs), where most cases of ALL Occur. Over the past several decades partnerships (twinning) between HIC and LIC. pediatric oncology programs have led to major improvements in outcome for children with ALL in some LICs, often by developing time and resource v intensive relationships that allow LIC centers to treat children with regimens similar or identical to those used in HICs. However, the resources are not available in most LICs to allow immediate introduction of intensive M I treatment regimens similar to those used in HICs. With these thoughts in mind, we present a proposal for a systematic and graduated approach to ALL diagnosis, risk classification, and treatment in LICs. We have based the strategy and the proposed regimen,, oil those developed by the Children's Cancer Croup (CCG) and Children's Oncology Group (COG) over the past several decades, beginning with a first level regimen similar to CCG therapy of file early 1980s and then layering on Successive treatment intensifications proven effective in randomized clinical trials. Simple monitoring rules arc, included to help centers decide when they are ready to add new treatment components. This proposal provides a framework that LIC centers can use to provide effective ALL therapy, particularly in regions of the world where few children are currently being cured. Pediatr Blood Cancer 2009;52: 559-565. (C) 2009 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据